Watson to Market Generic Avapro

Watson plans to immediately begin shipping its generic versions of Sanofi’s hypertension treatment Avapro after receiving FDA approval to market the generic version. Watson will have a slew of generic competitors for irbesartan, including Lupin, which received ANDA approval Oct. 15, Mylan, Sandoz, Teva and Dr. Reddy’s. Watson will offer the 75-mg, 150-mg and 300-mg versions of the drug.
Generic Line